HK1201919A1 - Vibrio cholerae lipoprotein 15 (lp15) variants as anti-interference additive in tpn17-based immunoassays for detection of anti-treponema antibodies vclp15 tpn17 - Google Patents

Vibrio cholerae lipoprotein 15 (lp15) variants as anti-interference additive in tpn17-based immunoassays for detection of anti-treponema antibodies vclp15 tpn17

Info

Publication number
HK1201919A1
HK1201919A1 HK15102351.2A HK15102351A HK1201919A1 HK 1201919 A1 HK1201919 A1 HK 1201919A1 HK 15102351 A HK15102351 A HK 15102351A HK 1201919 A1 HK1201919 A1 HK 1201919A1
Authority
HK
Hong Kong
Prior art keywords
tpn17
vclp15
variants
detection
vibrio cholerae
Prior art date
Application number
HK15102351.2A
Other languages
English (en)
Chinese (zh)
Inventor
Elke Faatz
Peter Schaarschmidt
Urban Schmitt
Christian Scholz
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of HK1201919A1 publication Critical patent/HK1201919A1/xx

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/28—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Vibrionaceae (F)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/245—Escherichia (G)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5306—Improving reaction conditions, e.g. reduction of non-specific binding, promotion of specific binding
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/571—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses for venereal disease, e.g. syphilis, gonorrhoea
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/35—Fusion polypeptide containing a fusion for enhanced stability/folding during expression, e.g. fusions with chaperones or thioredoxin
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/20—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Spirochaetales (O), e.g. Treponema, Leptospira
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/28—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Vibrionaceae (F)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2469/00—Immunoassays for the detection of microorganisms
    • G01N2469/20—Detection of antibodies in sample from host which are directed against antigens from microorganisms
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/26—Infectious diseases, e.g. generalised sepsis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Peptides Or Proteins (AREA)
HK15102351.2A 2013-07-18 2015-03-09 Vibrio cholerae lipoprotein 15 (lp15) variants as anti-interference additive in tpn17-based immunoassays for detection of anti-treponema antibodies vclp15 tpn17 HK1201919A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP20130003633 EP2827146A1 (en) 2013-07-18 2013-07-18 Vibrio cholerae lipoprotein 15 (Lp15) variants as anti-interference additive in TpN17-based immunoassays for detection of anti-Treponema antibodies

Publications (1)

Publication Number Publication Date
HK1201919A1 true HK1201919A1 (en) 2015-09-11

Family

ID=48874753

Family Applications (1)

Application Number Title Priority Date Filing Date
HK15102351.2A HK1201919A1 (en) 2013-07-18 2015-03-09 Vibrio cholerae lipoprotein 15 (lp15) variants as anti-interference additive in tpn17-based immunoassays for detection of anti-treponema antibodies vclp15 tpn17

Country Status (7)

Country Link
US (1) US9714949B2 (xx)
EP (2) EP2827146A1 (xx)
JP (1) JP6374720B2 (xx)
CN (1) CN104297477B (xx)
CA (1) CA2856627C (xx)
ES (1) ES2623891T3 (xx)
HK (1) HK1201919A1 (xx)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108780092A (zh) 2016-03-07 2018-11-09 豪夫迈·罗氏有限公司 抗p53抗体的检测
CN115112897A (zh) * 2021-12-10 2022-09-27 中山大学附属第八医院（深圳福田） 一种用于鉴别抗体检测生物学假阳性的方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3827409B2 (ja) * 1997-07-07 2006-09-27 株式会社トクヤマ 免疫学的測定方法
EP2267452B8 (en) 2001-06-22 2012-11-14 Roche Diagnostics GmbH A soluble complex comprising a retroviral surface glycoprotein
DE10207135A1 (de) * 2002-02-20 2003-09-11 Euroimmun Gmbh Verfahren und Kit zum Nachweis von spezifischen Antikörpern mittels Immunfluoreszenz
CN101363860A (zh) * 2007-08-06 2009-02-11 北京科美东雅生物技术有限公司 梅毒螺旋体抗体化学发光免疫分析测定试剂盒及其制备方法
EP2127678A1 (en) * 2008-05-26 2009-12-02 Roche Diagnostics GmbH SlpA as a tool for recombinant protein and enzyme technology
CN101858915A (zh) * 2010-05-19 2010-10-13 厦门大学附属中山医院 梅毒特异性IgG抗体胶体金免疫层析检测试剂条及其制备方法

Also Published As

Publication number Publication date
CA2856627C (en) 2018-08-14
EP2827146A1 (en) 2015-01-21
EP2827147A1 (en) 2015-01-21
CA2856627A1 (en) 2015-01-18
JP2015028479A (ja) 2015-02-12
ES2623891T3 (es) 2017-07-12
CN104297477A (zh) 2015-01-21
US9714949B2 (en) 2017-07-25
EP2827147B1 (en) 2017-03-01
JP6374720B2 (ja) 2018-08-15
US20150132859A1 (en) 2015-05-14
CN104297477B (zh) 2018-07-06

Similar Documents

Publication Publication Date Title
HK1222865A1 (zh) 通過施用 抑制劑抑制動脈粥樣硬化的方法
SG11201602002XA (en) Lubricant compositions for direct injection engines
EP2734939A4 (en) METHOD FOR SOCIAL RESEARCH
EP2788507A4 (en) METHOD FOR MEASURING IMMUNE ACTIVATION
EP2753814A4 (en) AERIAL ADDITIVE DISTRIBUTION SYSTEM
GB201315851D0 (en) Antibodies to complex targets
GB201700075D0 (en) Methods to reduce gas carry-uder for cyclonic seperators
IL228073A0 (en) Method for the determination of polysorbate
PL2770255T3 (pl) Sposób spalania paliwa
EP2816285A4 (en) DOUBLE VENTURI FOR COMBUSTION APPARATUS
FR2993311B1 (fr) Dispositif de deshuilage pour une turbomachine
EP2693043A4 (en) ENGINE STARTING APPARATUS
EP2997361A4 (en) PROCEDURE FOR DETECTING OIL RUNNING
FR3013762B1 (fr) Pompe pour additif
EP2922543A4 (en) SUBSTITUTED PYRIDONE DERIVATIVES AS PDE10 INHIBITORS
HK1213885A1 (zh) 作為 抑制劑的咪唑並-三嗪衍生物
HK1205197A1 (en) Assays for detection of glycosaminoglycans
HK1201919A1 (en) Vibrio cholerae lipoprotein 15 (lp15) variants as anti-interference additive in tpn17-based immunoassays for detection of anti-treponema antibodies vclp15 tpn17
RS58999B1 (sr) Integrisan proces za pripremu jedinjenja korisnih kao komponente goriva
ZA201403991B (en) Device for dosing an additive solution
PL2670250T3 (pl) Nowy proces przygotowania stabilnej emulsji oleju w wodzie bez dodatków
FR2993312B1 (fr) Dispositif de deshuilage pour une turbomachine
ZA201208738B (en) Oil soluble additive injection apparatus
FR2976982B1 (fr) Soufflante pour turboreacteur
HK1221495A1 (zh) 油溶性添加劑注射裝置